ALNYLAM PHARMACEUTICALS, INC. ($ALNY)
Filing Information
| Accession Number | 0001735276-26-000060 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 6, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
2,309
Total Value
$745,983.83
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Commercial Officer | Common Stock | โ | Mar 4, 2026 | Sale | 106 | $319.03 | $33,817.18 | 36,500 | Direct | โ | View Details | |
EVP, Chief Commercial Officer | Common Stock | โ | Mar 4, 2026 | Sale | 102 | $320.01 | $32,641.02 | 36,398 | Direct | โ | View Details | |
EVP, Chief Commercial Officer | Common Stock | โ | Mar 4, 2026 | Sale | 215 | $320.81 | $68,974.15 | 36,183 | Direct | โ | View Details | |
EVP, Chief Commercial Officer | Common Stock | โ | Mar 4, 2026 | Sale | 289 | $321.82 | $93,005.98 | 35,894 | Direct | โ | View Details | |
EVP, Chief Commercial Officer | Common Stock | โ | Mar 4, 2026 | Sale | 350 | $323.01 | $113,053.50 | 35,544 | Direct | โ | View Details | |
EVP, Chief Commercial Officer | Common Stock | โ | Mar 4, 2026 | Sale | 767 | $323.84 | $248,385.28 | 34,777 | Direct | โ | View Details | |
EVP, Chief Commercial Officer | Common Stock | โ | Mar 4, 2026 | Sale | 272 | $324.88 | $88,367.36 | 34,505 | Direct | โ | View Details | |
EVP, Chief Commercial Officer | Common Stock | โ | Mar 4, 2026 | Sale | 208 | $325.67 | $67,739.36 | 34,297 | Direct | โ | View Details |